SUSAN LEE: Open Payments
NPI 1376846618 · EASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 26 payments from 13 companies in 2025. Trend: 2023 $1,250 · 2024 $1,741 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $111 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Astellas Pharma US Inc | 2 | $39 |
| Amgen Inc. | 2 | $29 |
| PFIZER INC. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: JARDIANCE, Ozempic, TRELEGY ELLIPTA, Veozah, OTEZLA, SHINGRIX, BREZTRI, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
